Showing results (541-550 of 551) with videos related to

Sort By:
Pageof 56
JCO Precision Oncology|August 11, 2022
Association of ERBB2 Copy Number and Gene Coalterations With Trastuzumab Efficacy and Resistance in Human Epidermal Growth Factor Receptor 2-Positive Esophagogastric and Gastric CancerKaori Hino, Tomohiro Nishina, Takeshi Kajiwara, et al.
Antiviral Therapy|August 17, 2010
Safety and antiviral activity of JTK-652: a novel HCV infection inhibitorJoep de Bruijne, Jilling F Bergmann, Christine J Weegink, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
WJOG18524G: a single-arm phase II study evaluating bemarituzumab combined with ramucirumab and paclitaxel in fibroblast growth factor receptor 2b (FGFR2b)-positive advanced gastric or gastroesophageal junction cancer (RAINBIRD)K Shimozaki, K Hirata, H Hayashi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 31, 2024
Prevalence and clinicopathological features of microsatellite instability-high metastatic or recurrent gastric and esophagogastric junction cancer: WJOG13320GPSAzusa Komori, Shuichi Hironaka, Shigenori Kadowaki, et al.
Journal of Virology|January 11, 2019
USP15 Participates in Hepatitis C Virus Propagation through Regulation of Viral RNA Translation and Lipid Droplet FormationShinji Kusakabe, Tatsuya Suzuki, Yukari Sugiyama, et al.
International Journal of Clinical Oncology|March 4, 2026
Comparison of first-line cetuximab and panitumumab plus doublet chemotherapies for left-sided colorectal cancer: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and RectumRyosuke Kawagoe, Toshikazu Moriwaki, Kentaro Yamazaki, et al.
Frontiers in Oncology|July 2, 2021
Clinical Impact of Primary Tumor Location in Metastatic Colorectal Cancer Patients Under Later-Line Regorafenib or Trifluridine/Tipiracil TreatmentHiromichi Nakajima, Shota Fukuoka, Toshiki Masuishi, et al.
Frontiers in Oncology|March 25, 2021
Survival Benefit of Crossover Administration of Regorafenib and Trifluridine/Tipiracil Hydrochloride for Patients With Metastatic Colorectal Cancer: Exploratory Analysis of a Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (REGOTAS)Keigo Chida, Daisuke Kotani, Toshikazu Moriwaki, et al.
International Journal of Cancer|July 23, 2025
Ramucirumab-containing chemotherapy for patients with gastrointestinal neuroendocrine carcinoma refractory/intolerant to platinum-based chemotherapy: A multicenter observational retrospective study (WJOG13420G)Yuki Matsubara, Toshiki Masuishi, Waki Hosoda, et al.
BMC Cancer|October 31, 2023
Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from JapanKenji Tsuchihashi, Mamoru Ito, Shuji Arita, et al.
Pageof 56